Fabrication of osteoconductive scaffold with osteoinductive capability and appropriate resorption rate is of great significance for treating bone defects. To achieve this aim, strontium-substituted calcium sulfate hemihydrate (Sr-CSH) and hydroxyapatite (HA) were mixed to develop a novel composite. Sr-CSH containing 5% and 10% strontium was mixed with HA at the weight ratio of 6:4, respectively. Female Sprague-Dawley rats underwent bone defect surgery in left tibia were randomly assigned to three different treatment groups filled with CSH/HA, 5% and 10% Sr-CSH/HA. Micro-CT analysis showed increased new bone formation in 10% Sr-CSH/HA group compared to CSH/HA group. In addition, histological analysis showed large amounts of chondrocytes and osteoblasts within the pores of Sr-CSH/HA composites as a result of the CSH resorption. Further, CFU-F assay demonstrated the increased amount of bone marrow mesenchymal stromal cells (BMSCs) colonies in 10% Sr-CSH/HA group. In primary BMSCs, extraction from Sr-CSH/HA composite significantly increased the migration of cells, up-regulated the expression of osteoblastic marker genes, and increased the area of mineralized nodules. Together, Sr-CSH/HA may promote bone formation by recruiting and stimulating osteogenic differentiation of BMSCs. Therefore, this composite may be proposed as an ideal substitute to repair bone defects.
de BakkerCMJTsengWJLiY, et al.
Clinical evaluation of bone strength and fracture risk. Curr Osteoporos Rep2017;
15: 32–42.
2.
HenchLLThompsonI.Twenty-first century challenges for biomaterials. J R Soc Interface2010;
7: s379–391.
3.
GiannoudisPVDinopoulosHTsiridisE.Bone substitutes: an update. Injury2005;
36: S20–S27.
4.
KhanSNCammisaFPJrSandhuHS, et al.
The biology of bone grafting. J Am Acad Orthop Surg2005;
13: 77–86.
5.
BeuerleinMJMcKeeMD.Calcium sulfates: what is the evidence?J Orthop Trauma2010;
24: s46–51.
6.
KhanYYaszemskiMJMikosAG, et al.
Tissue engineering of bone: material and matrix considerations. J. Bone Joint Surg Am2008;
90: 36–42.
7.
SirkaARainaDBIsakssonH, et al.
Calcium sulphate/hydroxyapatite carrier for bone formation in the femoral neck of osteoporotic rats. Tissue Eng Part A2018;
24: 1753–1764.
8.
ChaiFRaoulGWissA, et al.
Bone substitutes: classification and concerns. Rev Stomatol Chir Maxillofac2011;
112: 212–221.
9.
WuCTXiaLGHanPP, et al.
Europium-containing mesoporous bioactive glass scaffolds for stimulating in vitro and in vivo osteogenesis. ACS Appl Mater Interfaces2016;
8: 11342–11354.
10.
CacciottiI.Bivalent cationic ions doped bioactive glasses: the influence of magnesium, zinc, strontium and copper on the physical and biological properties. J Mater Sci2017;
52: 8812–8831.
11.
PilmaneMSalma-AncaneKLocaD, et al.
Strontium and strontium ranelate: historical review of some of their functions. Mater Sci Eng C Mater Biol Appl2017;
78: 1222–1230.
12.
PengSLiuXSZhouG, et al.
Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. J Bone Miner Res2011;
26: 1272–1282.
13.
RaySThormannUEichelrothM, et al.
Strontium and bisphosphonate coated iron foam scaffolds for osteoporotic fracture defect healing. Biomaterials2018;
157: 1–16.
14.
MaoLXiaLChangJ, et al.
The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration. Acta Biomater2017;
61: 217–232.
15.
ZhaoFLeiBLiX, et al.
Promoting in vivo early angiogenesis with sub-micrometer strontium contained bioactive microspheres through modulating macrophage phenotypes. Biomaterials2018;
178: 36–47.
16.
CampanaVMilanoGPaganoE, et al.
Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med2014;
25: 2445–2461.
17.
Fernandez de GradoGKellerLIdoux-GilletY, et al.
Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng2018;
9: 2041731418776819.
18.
LiXXuCPHouYL, et al.
A novel resorbable strontium-containing α-calcium sulfate hemihydrate bone substitute: a preparation and preliminary study. Biomed Mater2014;
9: 045010.
19.
ChenYRZhouYLYangSY, et al.
Novel bone substitute composed of chitosan and strontium-doped α-calcium sulfate hemihydrate: fabrication, characterisation and evaluation of biocompatibility. Mater Sci Eng C Mater Biol Appl2016;
66: 84–91.
20.
YangSYWangLFengSB, et al.
Enhanced bone formation by strontium modified calcium sulfate hemihydrate in ovariectomized rat critical-size calvarial defects. Biomed Mater2017;
12: 035004.
21.
NilssonMWielanekLWangJS, et al.
Factors influencing the compressive strength of an injectable calcium sulfate-hydroxyapatite cement. J Mater Sci Mater Med2003;
14: 399–404.
22.
Pors NielsenS.The biological role of strontium. Bone2004;
35: 583–588.
23.
MaçonALKimTBValliantEM, et al.
A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J Mater Sci Mater Med2015;
26: 115.
24.
RibeiroLLBoscoAFNagataMJ, et al.
Influence of bioactive glass and/or acellular dermal matrix on bone healing of surgically created defects in rat tibiae: a histological and histometric study. Int J Oral Maxillofac Implants2008;
23: 811–817.
25.
LiHGhazanfariRZacharakiD, et al.
Isolation and characterization of primary bone marrow mesenchymal stromal cells. Ann N Y Acad Sci2016;
1370: 109–118.
26.
SiclariVAZhuJAkiyamaK, et al.
Mesenchymal progenitors residing close to the bone surface are functionally distinct from those in the central bone marrow. Bone2013;
53: 575–586.
27.
da Silva MeirellesLChagastellesPCNardiNB.Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci2006;
119: 2204–2213.
28.
ChandraALanSZhuJ, et al.
PTH prevents the adverse effects of focal radiation on bone architecture in young rats. Bone2013;
55: 449–457.
29.
HuangSXuLSunY, et al.
An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J Orthop Translat2015;
3: 26–33.
30.
ZhangCLLiZHLiQH, et al.
Properties and osteogenicity of two calcium sulfate materials with micro or nano morphology. J Nanosci Nanotechnol2016;
16: 2277–2282.
31.
O’ConnellJHLeeMEYagoubMYA, et al.
Characterization of crystallite morphology for doped strontium fluoride nanophosphors by TEM and XRD. Phys B2016;
480: 169–173.
32.
RobinsonLSalma-AncaneKStipnieceL, et al.
The deposition of strontium and zinc co-substituted hydroxyapatite coatings. J Mater Sci Mater Med2017;
28: 51.
33.
FergusonJDiefenbeckMMcNallyM.Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Jt Infect2017;
2: 38–51.
34.
BonnelyeEChabadelASaltelF, et al.
Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone2008;
42: 129–138.
35.
BrennanTCRybchynMSGreenW, et al.
Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol2009;
57: 1291–1300.
36.
SchumacherMLodeAHelthA, et al.
A novel strontium(II)-modified calcium phosphate bone cement stimulates human-bone-marrow-derived mesenchymal stem cell proliferation and osteogenic differentiation in vitro. Acta Biomater2013;
9: 9547–9557.
37.
PengSZhouGLukK, et al.
Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem2009;
23: 165–174.
38.
TsaiYYWangSFKuoST, et al.
Improving biodegradation behavior of calcium sulfate bone graft tablet by using water vapor treatment. Mater Sci Eng C Mater Biol Appl2013;
33: 121–126.
39.
RamayHRZhangM.Biphasic calcium phosphate nanocomposite porous scaffolds for load-bearing bone tissue engineering. Biomaterials2004;
25: 5171–5180.
